LONA
Biotechnology · Healthcare
COO, CEO, Board Member
2021-01-01–present
Equibles does not estimate personal net worth.
Mark Litton is recorded as CEO at LeonaBio, Inc. (LONA) since October 18, 2021, Board Member at LeonaBio, Inc. (LONA) since January 1, 2021 and COO at LeonaBio, Inc. (LONA). The newest filing on record that lists Mark Litton as Board Member at LeonaBio, Inc. (LONA) is dated May 11, 2026. The newest filing on record that lists Mark Litton as COO at LeonaBio, Inc. (LONA) is dated April 16, 2021. The proxy statement of LeonaBio, Inc. reports total compensation of $1,423,814 for Mark Litton in fiscal 2025, including a base salary of $625,000. Disclosed compensation is on record for 5 fiscal years. LeonaBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LeonaBio, Inc. includes Andrew Gengos (CFO), Robert Renninger (CFO and Chief Accounting Officer), Mark Worthington (General Counsel) and 7 others.
2021-10-18–present
2021-01-01–present
Last confirmed May 11, 2026
Start not stated–present
Last confirmed April 16, 2021
LONA
Biotechnology · Healthcare
COO, CEO, Board Member
2021-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | LeonaBio, Inc. (LONA) | Ph.D., President and Chief Executive Officer | $625,000 | $1,423,814 |
| 2024 | LeonaBio, Inc. (LONA) | Ph.D., President and Chief Executive Officer | $625,000 | $3,175,009 |
| 2023 | LeonaBio, Inc. (LONA) | Ph.D., President and Chief Executive Officer | $585,000 | $2,276,537 |
| 2022 | LeonaBio, Inc. (LONA) | Ph.D., President and Chief Executive Officer | $543,400 | $3,775,199 |
| 2021 | LeonaBio, Inc. (LONA) | Ph.D., President and Chief Executive Officer | $450,000 | $2,954,689 |
No call appearances or filed executive changes recorded yet.